Publication: 2128

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 33 (21) 2361-2369
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
4
Parents:
757  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA77597, CA04457, CA11789, CA77406, CA47577, CA35113, CA29165, CA41287, U10 CA021115, U10 CA031946, CA77651, U10 CA033601, CA59518, CA60138, U10 CA180821, CA26806, CA37447, CA45808, CA35279, CA12046, CA35421, CA86726, P30 CA008748, CA16450, U10 CA180791, CA77440, CA45564, CA04326, CA08025, CA74811, U10 CA180882, CA21060, CA47559, CA47642, CA45418, U10 CA180833, CA77658, CA77298, U10 CA180838, CA114558, U10 CA025224  
Corr. Author:
 
Authors:
                           
Networks:
CA824, HEARTLAND, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, PR028   
Study
CALGB-40502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Bc5, ORIGINAL REPORTS, Breast Cancer